DEXLANSOPRAZOL TAKEDA 30mg modified release capsules medication leaflet

A02BC06 dexlansoprazole • Alimentary tract and metabolism | Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) | Proton pump inhibitors

Dexlansoprazole is a medication used to treat gastrointestinal conditions such as gastroesophageal reflux disease (GERD) and erosive esophagitis. It belongs to the class of proton pump inhibitors (PPIs) and works by reducing the production of stomach acid.

The medication is taken orally, usually once daily, regardless of meals. Dexlansoprazole is effective in relieving heartburn symptoms and promoting the healing of the esophageal lining.

Side effects may include nausea, diarrhea, headaches, or constipation. In rare cases, long-term use may lead to vitamin B12 deficiency or an increased risk of bone fractures.

Patients should strictly follow their doctor's instructions and inform them about any other medications they are taking. Pregnant or breastfeeding women should consult a specialist before use.

General data about DEXLANSOPRAZOL TAKEDA 30mg

Substance: dexlansoprazole

Date of last drug list: 01-07-2014

Commercial code: W60509002

Concentration: 30mg

Pharmaceutical form: modified release capsules

Quantity: 28

Product type: generic

Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Concentrations available for dexlansoprazole

30mg, 60mg